within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J04A_DrugsForTreatmentOfTuberculosis.J04AB06_Enviomycin;
model Enviomycin 
   extends Pharmacolibrary.Drugs.ATC.J.J04AB06;

  annotation(Documentation(
    info ="<html><body><p>Enviomycin is an aminoglycoside antibiotic formerly used primarily for the treatment of tuberculosis, particularly multidrug-resistant Mycobacterium tuberculosis. It is not widely approved or used today, having largely been replaced by other agents due to its side effect profile and availability of alternatives.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for a typical adult patient; no direct human clinical literature source was found. Values are based on typical pharmacokinetics of aminoglycosides and limited available animal studies.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Enviomycin;
